NASDAQ
Newron Pharmaceuticals S.p.A. (NWPHF) has a free cash flow growth of 289.50% as of Friday, May 29, 2026. This represents a 1592.50% increase compared to its 12-month average of -19.40%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.